Singapore: cold & cough remedies market revenue 2016-2027

The revenue in the cold & cough remedies segment of the OTC pharmaceuticals market in Singapore was forecast to continuously increase between 2023 and 2027 by in total 65.5 million U.S. dollars (+24.21 percent). The revenue is estimated to amount to 336.09 million U.S. dollars in 2027.

Find other key market indicators concerning the cold & cough remedies segment of the OTC pharmaceuticals market in Singapore, such as average revenue per user (ARPU) and revenue growth.

Revenue of the cold & cough remedies market in Singapore from 2016 to 2027 (in million U.S. dollars)

Characteristic	Revenue in million U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

More information

Supplementary notes

Data provided by Statista Market Insights are estimates.

The Cold and Cough segment comprises over-the-counter natural and synthetic agents to relieve cough, expectorants and sore throat remedies, cold remedies and preparations against flu-like infections. Cough and cold medication includes medicines in the form of pills, syrups, lozenges, sprays, ointments and granulate for external and internal application. Not included are prescription medicines, preparations that are against the state law or are no explicit cold or cough drugs (e.g. painkillers). Among the top-selling medicines for cold and cough are nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, Isla Moos. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Citation formats